Healthcare Growth and Strategy Dental Implants Manufacturers

Healthcare Growth and Strategy Dental Implants Manufacturers

September 16, 2019
September 16, 2019

Share

For a Dental Implants Manufacturer, Stax Completed a Global Segmentation Study to Help the Company Focus Growth

THE SITUATION

  • For the portfolio company of a private equity firm, Stax sought to:
  • Identify and size actionable customer segments and determine the main factors that made each segment unique (such that they could align with the Company’s go-to-market strategy); complete a gap analysis of unmet/underserved needs; understand the growth rate of each segment to identify significant opportunities for the Company.
  • Defined the “adoption pathway” by determining how needs differed along the lifecycle: user mix changes between GP dentists and surgeons; trends in GP adoption of surgical procedures; drivers of/hindrances to adoption.
  • Map the referral patterns to highlight opportunities/pitfalls to growing the market when considering the “ecosystem” of dental implants which included GP dentists, referents, and manufacturers.


THE ASSIGNMENT

  • Stax went deep in collecting direct feedback from dentists, surgeons, and competitors in the dental implants space. We completed over 1,200 interviews across 11 countries targeting: GP dentists, periodontists, endodontists, prosthodontists, and implantologists via a combination of direct in-person interviews, phone interviews, and a web survey.
  • This data served as the fact base from which we completed our customer segmentation and profiling analysis as well as sizing the future market opportunity based on adoption intent.

THE BENEFITS

  • Stax work provided the Company with an in-depth understanding of unique customer segments with a clearly articulated go-to-market path for better serving each and driving incremental revenues on a country-by-country basis. Further, we were able to map the adoption pathway and drivers to answer for the company the opportunity vs. risk of having GP dentists performing implant surgery and the potential impact to the core surgeon business. We recommended a strategy to minimize channel conflict and leverage the referral network for all interested parties.

Read More

Grant Thornton Stax Advises Thoma Bravo on Merger of Hypergene & Stratsys
December 19, 2025
Grant Thornton Stax recently supported Hypergene, a portfolio management solutions backed by Thoma Bravo, on its recent merger with Stratsys. Read about the deal here.
Grant Thornton Stax Community ERG Unites to Give Back
December 17, 2025
Our teams across the US offered to spread some holiday cheer, rallying together to donate toys to local charities. Read about our various efforts, as well as charities you can donate to.
Grant Thornton Stax Sell-side: Pairsoft Investment by TA Assoc.
December 17, 2025
Grant Thornton Stax supported Pairsoft, a leading provider of procure-to-pay automation and payment solutions, on its recent majority growth investment by TA Associates. Read more.
Grant Thornton Stax Sell-side Support: Moss Acquisition by Vomela
December 17, 2025
Grant Thornton Stax recently supported Moss, a global producer of innovative brand experiences, on its acquisition by Vomela, a Riverside Company. Read more about the deal here.
Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Show More